x
ServiziMenu principaleHome
You are here: Home > Media & Publications > Social Feeds
Print

Social Feeds

March 31, 202004:00 PM
March 31, 202011:52 AM
It has become clear that more specific recommendations are needed to help treatment teams strengthen their clinical management of patients and support decision-making processes during the COVID-19 pandemic. Don’t hesitate to submit a question or comment on todays e-session on ...
March 31, 202011:07 AM
March 31, 202011:00 AM
March 30, 202006:21 PM
March 30, 202006:14 PM
March 30, 202004:26 PM
ESO is looking for Ambassadors to help promote its activities in the Balkan/Eastern European region. If you are interested send us your application by 1st April. Link in bio
March 30, 202004:05 PM
March 30, 202012:30 PM
March 30, 202008:51 AM
March 27, 202004:00 PM
March 27, 202003:00 PM
March 27, 202011:48 AM
March 27, 202011:03 AM
March 26, 202011:47 AM
March 26, 202011:35 AM
March 24, 202004:50 PM
Historically, mCRC was considered non-immunogenic. However, immunotherapy has been shown to be efficacious in hypermutated tumours, such as MSI-H/dMMR colorectal cancer. .
May 2017 - FDA licensed pembrolizumab in previously treated dMMR mCRC and in August 2017 nivolumab in dMMR ...
March 19, 202002:17 PM
Journalists from Germany, Belgium, Kenya and Mexico have been recognised for their outstanding achievement in the 2019-20 Cancer Journalism Award CONGRATULATIONS to Overall winner Anne Preger and category winners Elijah Kanyi, Myriam Vidal Valero, Rodrigo Pérez, Nelly Toche & Patrice ...
March 16, 202003:53 PM
Extra #e_eso session this week, Wednesday 18 March at 18:15 (CET) on The Impact of Coronavirus on Oncological Care with @siano23, Alexandru Eniu and @SCafarotti. Important topic in these difficult times. #coronavirus #wontstopus http://bit.ly/2w1XmEb #oncoalert
March 14, 202007:40 AM
Don't miss this Live streamed session via Twitter on 17 March at 18:00 (CET). #prostatecancer #pcsm

Load More

Follow us